Plain-English translation of NCT06741332 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Stroke research guide →This study is testing whether a new AI software called Methinks Stroke Suite can help doctors at local stroke centers work faster and make better decisions about which patients need to be transferred for advanced stroke treatment. The software analyzes brain imaging to identify patients who may benefit from a procedure called thrombectomy. Researchers want to see if using this tool speeds up the process of getting patients the care they need.
When someone has a stroke caused by a blood clot, every minute counts. Currently, doctors at hospitals without advanced stroke surgery capabilities must make transfer decisions relatively slowly, which can delay life-saving treatment. This trial aims to see whether the new treatment can help doctors work faster and more accurately, so more patients get to specialized centers in time.
You likely qualify if…
You likely don't qualify if…
If you are enrolled, you will receive standard stroke care at your local hospital, but your brain imaging will also be analyzed by the new AI software to help doctors decide whether to transfer you to a specialized stroke center. You will be followed for 90 days after your stroke to see how well you recover. The study compares outcomes for patients evaluated with the new software tool to outcomes from similar patients treated before the tool was available.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Spain